A neutrophil heterogeneity related gene signature predicts prognosis and reveals regulatory mechanism of tumor immune microenvironment in colorectal cancer
A dual-gene model based on neutrophil heterogeneity demonstrated strong predictive performance and functioned as an independent prognostic indicator, and distinct immune and prognostic differences were identified among molecular subtypes.
Abstract
This study aims to construct a prognostic model based on neutrophil heterogeneity by integrating single-cell and bulk transcriptomic data. Additionally, it seeks to explore the features of the immune microenvironment across different risk subgroups to facilitate precise prognostic assessment and individualized immunotherapy for colorectal cancer.
Colorectal cancer transcriptomic datasets from TCGA and GEO were utilized. Single-cell data underwent quality control, clustering, and cell annotation. Cell communication analysis characterized neutrophil signaling interactions. Candidate genes were identified through differential expression analysis and WGCNA, leading to the establishment and validation of a CCL15/CCDC154 dual-gene prognostic model. Differences in immune infiltration, immune checkpoint expression, and immune escape between high- and low-risk groups were analyzed, followed by molecular subtype clustering.
Significant remodeling of the tumor microenvironment was observed, with neutrophils extensively participating in multicellular signaling networks. The dual-gene model demonstrated strong predictive performance and functioned as an independent prognostic indicator. The high-risk group exhibited a pronounced immunosuppressive phenotype, characterized by significant immune escape and upregulated inhibitory immune checkpoints. Notably, distinct immune and prognostic differences were identified among molecular subtypes.
The dual-gene model based on neutrophil heterogeneity facilitates accurate prognostic stratification. The neutrophil-mediated immune microenvironment is closely linked to clinical outcomes, providing a theoretical basis for personalized treatment strategies in colorectal cancer.
Colorectal cancer (CRC) progression is closely associated with chronic inflammation and immune suppression mediated by M2 macrophages. This study systematically analyzed immune-related and macrophage polarization–related genes in CRC by integrating The Cancer Genome Atlas CRC dataset to identify differentially expr...
Yuan Yuan, Bing-Xi Zhou, Jin Liu et al.· Scientific Reports· 0 citations
A seven-gene immune-related prognostic signature that, combined with clinicopathological parameters, provides a robust tool for individualized survival prediction and may guide precision management in CRC patients is developed and validated.
This study proposes NET-related CRC molecular subtypes with oxidative stress-associated biological context and develops a transcriptomic risk model with external validation that suggests subtype-specific immune and therapeutic features, while prospective clinical and functional validation is required before clinical tr...
Yi Wei, Weijian Chu, Chunhui Rao et al.· Medicine· 0 citations
Background Melanoma is highly invasive with poor advanced-stage prognosis and remarkable heterogeneity of the tumor immune microenvironment. Lysine crotonylation regulates tumor progression and immune processes, yet its role in melanoma remains unclear. Purpose This study aims to explore the value of crotonylation-rela...
Chen Li, Xin-Yu Cui, Yong Yang et al.· International Journal of Gen...· 0 citations
A robust prognostic model based on four RhoGTPase-related prognostic genes was established, effectively stratifying LUAD patients and provides valuable insights into the heterogeneity of LUAD and has the potential to inform personalized therapeutic strategies.
Tian-Chuan Li, Dan-Hong Wu, A. Yang et al.· Scientific Reports· 0 citations
Tertiary lymphoid structures (TLSs) modulate immune responses in various solid tumors, but their comprehensive role in lung adenocarcinoma (LUAD) remains unclear. In this study, we analyzed RNA‐seq data from 539 LUAD patients in The Cancer Genome Atlas (TCGA) and microarray data from 223 samples from the Gene Expressio...
Si-Hong Le, Weidan Fang, Y. Le et al.· Cancer Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.